Our first ever Parkinson’s Life poetry competition attracted entries from around the world. Ahead of our interview with the winner next week, we caught up with runner-up Marc Woodward, on everything from how Parkinson’s “crept up on him” aged 54, what’s on his ‘bucket list’ – and the inspiration behind his fantastic poem ‘San Francisco’
The global response to our first ever poetry competition was overwhelming. It was a delight to read all of our reader’s poems, and a real challenge narrowing it down to just two entries. After careful deliberation we are delighted to announce Marc Woodward, who works in financial services and is based in Devon, UK, as our runner-up.
Marc, who was diagnosed with Parkinson’s in 2016, wrote his winning poem ‘San Francisco’ while on a writing retreat in Santa Cruz, US. The poem, which deals with feelings of nostalgia, hints at symptoms of the condition and references the idea of the ‘bucket list’ – all set against the colourful backdrop of San Francisco, US – really tells a story.
We caught up with Marc, who told us about his passion for poetry and music, his experience of the condition and why he doesn’t want to be known as ‘a poet with Parkinson’s’.
Why did you enter our competition?
I write a lot of poetry anyway, and I have Parkinson’s so I thought I should have a go! I don’t enter a lot of competitions usually.
Have you been published before?
I published a collection of poetry called ‘Hide Songs’ in 2018. My poetry has also featured in various publications and journals.
Are you a full-time poet?
Unfortunately not. I work in financial services. Every poet has a day job, even the greats. T.S. Eliot was a bank manager. I think it’s good to have a day job, as you need outside stimulus instead of just burying your head in books all the time.
When were you diagnosed with Parkinson’s?
I was diagnosed in January 2016 but I had been having symptoms for years without any idea what Parkinson’s was. I noticed that when I was playing music, I wasn’t moving as smoothly as before. I couldn’t play like I used to, and I just put it down to getting old. Parkinson’s crept up on me and I didn’t even realise it.
What was the inspiration behind ‘San Francisco’?
I wrote it while on a writing residency in Santa Cruz, US, last October. In the 80s I wanted to go to San Francisco to play music, but never did, which the poem reflects on. Finally, I went last year. So, it’s to do with a bit of a ‘bucket list’ thing really.
When you have Parkinson’s, you are looking down the barrel of a gun that has been fired with a bullet coming very slowly towards you. I decided I needed to make the most of the opportunities that come a long. That’s the positive side of the disease, you think “maybe there’ll be a cure one day” but in the meantime you need to just do things that you’ve always wanted to do.
Tell me about your experience of Parkinson’s.
So far, I’m really trying to reduce stress in my life, especially work-related stress. Sadly, I don’t play gigs any more, which had been a central part of my life for a long time. I can play okay, but I can’t play like I once could. It just doesn’t feel the same anymore. Parkinson’s has knocked my self-confidence, but it has also encouraged me to (as much as it is a cliché) ‘live for the moment’.
Do you find writing an outlet for your Parkinson’s?
I’m not sure. ‘San Francisco’ was not actually meant to be about Parkinson’s. It was meant to be about San Francisco but Parkinson’s came sneaking in! I am trying to avoid writing about Parkinson’s too much really, because I don’t want it to define me. I don’t want to be the ‘poet with Parkinson’s’. I just want to be who I am.
Who is your favourite poet?
There are lots. I like Edward Thomas, the British nature writer. I love the American writer Billy Collins, and Robert Frost. When writing ‘San Francisco’ I drew inspiration from all of them, but the poem’s particular narrative, spoken style comes from Billy Collins. Most of the stuff I usually write is very nature oriented.
Marc Woodward at his writing residency in Santa Cruz, US.
‘San Francisco’ by Marc Woodward
“It’s an odd thing but anyone who disappears is said to be seen in San Francisco.” – Oscar Wilde
Sundown sets the painted ladies dancing
on the eastern side of Alamo Square.
Clustered below Monterey cypresses
silhouettes watch dime-and-quarter fog
read bedtime stories to downtown suits.
I eat at the Absinthe bar in Hayes –
tomato bisque and a yellow Sauvignon.
The hipster barman shakes cocktails
like he’s summoning a djinn.
Like he’s wrestling the palsy.
At two a.m. I awake to a siren
and lie jet-lagged, cramping.
I recall years back in Manhattan
all-night sirens attention seeking
through the sodium limbo
and a high wall of windows
blinking on and off
– as if the whole building was trying its luck
in a giant game of tic-tac-toe.
I think about chance and odds.
San Francisco is quieter, calmer. Steadier.
At nineteen I wanted to move here,
play mandolin in the New Acoustic scene.
I bought Grisman LPs, a guide to the city,
studied bucket-shop flights in the Sunday papers.
Instead I stayed home, went to work,
married and made a family album.
And though I never doubted how right that was
being here at last eases an old pain.
I’m staying in a tall, bay-windowed Italianate
owned by a thin guy called Mike
– and Willy, his lilac poodle.
Mike has a harmonium and a baby grand.
They smile toothily at each other
across the Victorian drawing room
like the two gay lodgers who appear for breakfast
passing coffee back and forth across the table.
We chat about the downtown homeless and trams.
I sit on my trembling left hand.
The one which stumbles on frets where once it flew.
Insurance money in my jeans, I plan my last day in town.
7 New Year’s resolutions from the Parkinson’s community
Our readers share their goals for 2020
1 day ago
Study suggests why neurons die in Parkinson’s disease
Researchers at the University of Córdoba, Spain, have discovered how a certain protein may be linked to death of dopamine-producing neurons associated with Parkinson’s. Using animal models of the condition to conduct their study, the team focused on the protein DJ-1 – whose link to Parkinson’s has previously been established, though its exact function was uncertain. The researchers compared neurons in the brains of mice that possessed the gene expressing DJ-1 with those that did not. The findings revealed that dysfunction or absence of the gene expressing the DJ-1 protein could trigger the ‘cell cycle’ (the process by which cells divide), which should not occur under normal conditions. Because neurons lack the capacity to divide, this causes them die – leading to the onset of symptoms linked with Parkinson’s. It is hoped that uncovering these details about the relationship between DJ-1’s absence and Parkinson’s may lead to the development of…
Researchers have finally identified brain cells linked to Parkinson’s disease
For decades, scientists have known that Parkinson’s is associated with the death of dopamine-producing cells in the brain. Now, researchers from the Broad Institute of MIT and Harvard, US, have discovered the specific subtype of brain cells that die in Parkinson’s disease. Using a technique called single-cell RNA signalling, which enables the individual analysis of cells within a tissue for activity and protein production, researchers identified 10 subtypes of dopamine-producing cells within the donated brains of people who died from causes unrelated to Parkinson’s. The team carried out the same investigation on people who had died with Parkinson’s or a condition with similar symptoms called Lewy body dementia. They discovered that only one subtype of the cells had reduced in number – which suggests many of these cells had died while the people were living. It is hoped that the findings could lead to better understanding of Parkinson’s causes and…
Tiny DBS implant shows potential to advance Parkinson’s disease treatment
In an innovative trial by North Bristol NHS Trust, UK, surgeons have succeeded in implanting a tiny deep brain stimulation (DBS) device into a person’s skull. Their aim? To address symptoms of Parkinson’s. Designed with a tiny battery system that is inserted into the skull, the DBS device delivers electric impulses to targeted areas of the brain through electric probes. In doing so, it works to address abnormal brain cell activity associated with Parkinson’s – and may help to ease symptoms. One of around 25 patients selected for the year-long trial has described the device’s impact as “amazing”. Commenting on the results of the trial so far, consultant neurologist Dr Alan Whone of North Bristol NHS Trust said: “We are hopeful that if these findings hold up, we will have a significant technical advance by which to improve Parkinson’s care across the world.”